Last reviewed · How we verify
Acutran (amfecloral)
Acutran (generic name: amfecloral) is a drug. It is currently in unknown development.
Acutran is thought to work by influencing the body's stress response and possibly modulating the hypothalamic-pituitary-adrenal axis.
Acutran is a combination drug containing dextroamphetamine, a central nervous system stimulant, and chloral hydrate, a central nervous system depressant and sedative-hypnotic.
At a glance
| Generic name | amfecloral |
|---|---|
| Therapeutic area | Nephrology |
| Phase | unknown |
Mechanism of action
Imagine your body has a stress response system that helps you react to danger. Acutran may help regulate this system, reducing the negative effects of stress on the body. This could potentially help alleviate symptoms of stress-related conditions.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acutran CI brief — competitive landscape report
- Acutran updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Acutran
What is Acutran?
How does Acutran work?
What is the generic name of Acutran?
What development phase is Acutran in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Nephrology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing